statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The share price gained 80 percent in last one-year.

Torrent Pharma shares hit 52-week high on successful inspection by USFDA

Various drugs manufactured by listed players like Sun Pharmaceuticals, Alkem Laboratories, Cipla Ltd, Mankind Pharma, Lupin Ltda and Torrent Pharma are included in the list.

Diabetes, BP drugs to cost less as NPPA fixes retail prices of 69 formulations

Sharekhan is bullish on Torrent Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 2700 in its research report dated January 05, 2024.

Buy Torrent Pharmaceuticals; target of Rs 2700: Sharekhan

This was a Pre-Approval inspection conducted from 5 December to 11 December 2023.

US FDA releases detailed observations at Torrent's Chhatral unit; shares trade high

Torrent Pharmaceuticals Ltd. engages in the research, development, manufacture, and marketing of generic pharmaceutical formulations. It offers pharmaceutical products to local and international markets, particularly in countries such as India, USA, Germany, Brazil, and other countries. The company was founded by Uttambhai Nathalal Mehta in 1959 and is headquartered in Ahmedabad, India.

Torrent Pharmaceuticals Ltd.

Volume	146,666.00
52-Wk High	2,744.00
52-Wk Low	1,598.45

TORNTPHARM.NSE Torrent Pharmaceuticals Ltd.

About

Feed

News

Sentiment

Fundamentals

Sentiment

Message Volume

Community